uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
28 01 2020
Historique:
received: 20 12 2019
revised: 24 01 2020
accepted: 26 01 2020
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 13 2 2021
Statut: epublish

Résumé

Urokinase Plasminogen Activator (uPA) Receptor (uPAR) is a well-known GPI-anchored three-domain membrane protein with pro-tumor roles largely shown in all the malignant tumors where it is over-expressed. Here we have exploited the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene knock out approach to investigate its role in the oxidative metabolism in human melanoma and colon cancer as the consequences of its irreversible loss. Knocking out

Identifiants

pubmed: 32012858
pii: cells9020308
doi: 10.3390/cells9020308
pmc: PMC7072355
pii:
doi:

Substances chimiques

RNA, Guide 0
Receptors, Urokinase Plasminogen Activator 0
Lactic Acid 33X04XA5AT
CRISPR-Associated Protein 9 EC 3.1.-
Deoxyribonuclease I EC 3.1.21.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Oncotarget. 2014 Mar 30;5(6):1538-53
pubmed: 24681666
Aging (Albany NY). 2011 Mar;3(3):192-222
pubmed: 21422497
Anal Biochem. 2011 Jul 15;414(2):179-86
pubmed: 21402045
J Cell Mol Med. 2015 Sep;19(9):2262-72
pubmed: 26082201
Theranostics. 2013 Jun 25;3(7):496-506
pubmed: 23843897
J Natl Cancer Inst. 2002 Jan 16;94(2):116-28
pubmed: 11792750
Cell Physiol Biochem. 2018;47(5):1909-1924
pubmed: 29961070
Cell Metab. 2013 Sep 3;18(3):325-32
pubmed: 23850316
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846
Nat Rev Mol Cell Biol. 2002 Dec;3(12):932-43
pubmed: 12461559
Int J Cancer. 2017 Sep 15;141(6):1190-1200
pubmed: 28577299
Oncotarget. 2018 Jun 29;9(50):29414-29430
pubmed: 30034627
J Biol Chem. 2001 Feb 16;276(7):4756-65
pubmed: 11085980
Cell Mol Life Sci. 2006 May;63(9):1028-37
pubmed: 16465446
Front Aging Neurosci. 2018 Jan 08;9:435
pubmed: 29358916
Blood. 2016 Aug 4;128(5):667-79
pubmed: 27268090
Science. 2016 Jan 22;351(6271):400-3
pubmed: 26721683
EBioMedicine. 2019 Jan;39:194-206
pubmed: 30611716
Oncotarget. 2018 Jun 12;9(45):27823-27834
pubmed: 29963240
Nature. 2012 Feb 15;482(7385):331-8
pubmed: 22337052
Appl Environ Microbiol. 1992 Aug;58(8):2606-15
pubmed: 1381174
Cancer Res. 2004 Jun 1;64(11):3892-9
pubmed: 15172999
Nat Rev Mol Cell Biol. 2010 Jan;11(1):23-36
pubmed: 20027185
J Biol Eng. 2018 Dec 18;12:33
pubmed: 30574185
Cell Mol Life Sci. 2000 Jan 20;57(1):25-40
pubmed: 10949579
Cell Death Dis. 2015 Jul 30;6:e1835
pubmed: 26225774
Blood. 2011 Apr 14;117(15):4154-61
pubmed: 21304107
Int J Cancer. 2018 Aug 15;143(4):921-930
pubmed: 29524226
Cell Commun Signal. 2018 Nov 22;16(1):87
pubmed: 30466459
Oncotarget. 2014 May 15;5(9):2635-47
pubmed: 24797434
Oncotarget. 2014 Jun 15;5(11):3711-27
pubmed: 25003596
Int J Cancer. 2004 May 20;110(1):125-33
pubmed: 15054877
J Exp Clin Cancer Res. 2017 Jun 15;36(1):80
pubmed: 28619109
Clin Exp Metastasis. 2002;19(3):193-207
pubmed: 12067200
J Cell Biol. 1985 Jan;100(1):86-92
pubmed: 3880760
Gene Ther. 2005 Apr;12(8):702-14
pubmed: 15674398
Curr Pharm Des. 2011;17(19):1874-89
pubmed: 21711237
PLoS One. 2016 May 11;11(5):e0154576
pubmed: 27167619
Nat Biotechnol. 2015 Apr;33(4):390-394
pubmed: 25690852
Thromb Haemost. 2007 Mar;97(3):336-42
pubmed: 17334498
BMC Cancer. 2014 Apr 17;14:269
pubmed: 24742002
Curr Opin Cell Biol. 2000 Oct;12(5):613-20
pubmed: 10978898

Auteurs

Alessio Biagioni (A)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Anna Laurenzana (A)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Anastasia Chillà (A)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Mario Del Rosso (M)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Elena Andreucci (E)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Martina Poteti (M)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Daniele Bani (D)

Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134 Firenze, Italy.

Daniele Guasti (D)

Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134 Firenze, Italy.

Gabriella Fibbi (G)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Francesca Margheri (F)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni 50, 50134 Firenze, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH